IBL Tool - Digitale Bibliotheek

Digitale Bibliotheek

Sluiten

Tijdschrift beschrijving

Alle jaargangen van het bijbehorende tijdschrift

Alle afleveringen van het bijbehorende jaargang

Alle artikelen van de bijbehorende aflevering

34 gevonden resultaten

nr	titel	auteur	tijdschrift	jaar	jaarg.	afl.	pagina('s)	type
1	Abciximab to tirofiban switch not worth it			2003	437	1	p. 7	artikel
2	Antidepressants the modern-day sugar pill?			2003	437	1	p. 4	artikel
3	Antiretroviral deal negotiated by Clinton Foundation			2003	437	1	p. 11	artikel
4	Atypical antipsychotics decrease resource use			2003	437	1	p. 5	artikel
5	Β-Blocker, ACE inhibitor/ARB use in CHF			2003	437	1	p. 8	artikel
6	CABG costs most stable in CAD			2003	437	1	p. 6	artikel
7	Cost effective enfuvirtide a valuable tool for eastern Europe			2003	437	1	p. 5	artikel
8	Costs of care vary between stroke subtypes in Australia			2003	437	1	p. 9	artikel
9	Counselling on lifestyle changes worth the effort?			2003	437	1	p. 8	artikel
10	COX-2 inhibitor, NSAID prescribing patterns vary in Italy			2003	437	1	p. 7	artikel
11	COX-2 inhibitor prescribing weighed up in Australia			2003	437	1	p. 8	artikel
12	Drug sales growth in Finland hit by price competition			2003	437	1	p. 11	artikel
13	Economics not on agenda for ESC guideline development			2003	437	1	p. 2	artikel
14	Generics price hikes questioned in Indonesia			2003	437	1	p. 11	artikel
15	Guideline compliance mixed for acute MI in the US			2003	437	1	p. 8	artikel
16	Guidelines for the use of dietary supplements, nutraceuticals released			2003	437	1	p. 4	artikel
17	HRT use associated with women's attitudes towards therapy			2003	437	1	p. 7	artikel
18	Inappropriate care despite guidelines in ovarian cancer			2003	437	1	p. 5	artikel
19	Incontinence increases labour costs in US long-term care			2003	437	1	p. 10	artikel
20	Medicare approves implantation of heart assist devices			2003	437	1	p. 11	artikel
21	Mortality, long-term costs high in severe sepsis			2003	437	1	p. 10	artikel
22	New drugs listed on Australia's Pharmaceutical Benefits Scheme			2003	437	1	p. 11	artikel
23	Osteoporosis to cost > $US2b in Florida, US, by 2025			2003	437	1	p. 9	artikel
24	Oxycodone enhances QOL in painful diabetic neuropathies			2003	437	1	p. 10	artikel
25	Pharmacist intervention improves orlistat outcomes in obesity			2003	437	1	p. 7	artikel
26	Psychotropic prescribing common but “questionable”			2003	437	1	p. 5	artikel
27	QOL benefits observed with olanzapine in schizophrenia			2003	437	1	p. 10	artikel
28	Risperidone injection to be priced at premium to oral formulation			2003	437	1	p. 11	artikel
29	Significant cost savings with outpatient cardioversion in AF			2003	437	1	p. 6	artikel
30	Tacrolimus a cost-saving option in renal transplantation in Europe			2003	437	1	p. 3	artikel
31	Thromboprophylaxis use found lacking in south Australia			2003	437	1	p. 9	artikel
32	Traditional NSAIDs preferred for OA, RA in Korea			2003	437	1	p. 6	artikel
33	UK NICE issues guidance on imatinib mesylate . . .			2003	437	1	p. 2	artikel
34	$US16.8 million grant awarded for HIV vaccine			2003	437	1	p. 11	artikel

34 gevonden resultaten

Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland